Medical News

RSS

BME announces launch of Speed Arc Nitinol Fixation System

BioMedical Enterprises announced the launch of the Speed Arc Nitinol Fixation System, the world's first superelastic shape memory fixation device that conforms to the sloping surface of the metaphyseal anatomy. This addition to the current patented BME Speed Fixation System is available in three different sizes to ensure a proper fit in varying patient anatomies.

4 Dec 2014

CorMedix seeks QIDP designation from FDA for Neutrolin Catheter Lock Solution

CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious disease, has filed a request with the U.S. Food and Drug Administration for designation of its lead product candidate, Neutrolin Catheter Lock Solution, as a qualified infectious disease product (QIDP) pursuant to the Generating Antibiotic Incentives Now (GAIN) title of the Food and Drug Administration Safety and Innovation Act.

4 Dec 2014

Dr. Peter G. Goldschmidt announces recipients of Awards for Excellence in Human Research Protection

Awards for Excellence in Human Research Protection were announced today by Dr. Peter G. Goldschmidt, President and Founder of the Health Improvement Institute.

4 Dec 2014

Mylan gets tentative approval from FDA for two pediatric dosages of abacavir/lamivudine tablets

Mylan Inc. today announced that its subsidiary Mylan Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration for its New Drug Applications (NDAs) for two dosages of abacavir/lamivudine tablets for oral suspension for the treatment of HIV-1 infection in pediatric patients.

4 Dec 2014

Welch Allyn, LKC Technologies sign distribution agreement for RETeval DR screening device

Welch Allyn, a leading medical diagnostic device company that delivers pragmatic innovation at the point of care, and LKC Technologies, Inc., the worldwide leader in visual electrophysiology and inventor of the RETeval DR diabetic retinopathy assessment device announced an exclusive distribution agreement.

4 Dec 2014

MRIGlobal awarded $3 million contract to provide HPV vaccine

MRIGlobal today announced that it has been awarded a $3 million contract amendment from the National Cancer Institute's PREVENT Cancer Program to provide a vaccine for the Human Papillomavirus or HPV, the most common sexually transmitted infection in the United States. MRIGlobal will lead a team that will produce the vaccine to be used in a Phase I clinical trial.

4 Dec 2014

New drug offers hope for victims of spinal cord injury

Scientist in the U.S have developed a drug that could help paralysed victims of spinal cord injury regain their ability to move.

4 Dec 2014

Massage therapy: A natural way to strengthen the immune system this flu season

As seasons change our bodies become more susceptible to cold and flu. Massage therapy is a natural way to strengthen the immune system at this vulnerable time, especially if it is already weakened by stress, fatigue or poor nutrition.

4 Dec 2014

Pharmacyclics wins 2014 Society for Medicines Research Award for Drug Discovery

Pharmacyclics, Inc. today announced that it has won the prestigious 2014 Society for Medicines Research Award for Drug Discovery for its discovery of ibrutinib (IMBRUVICA). The award was presented by The Society of Medicines Research at its biennial award lecture in Kensington, London.

4 Dec 2014

myMEDholiday.com launches digital medical tourism destinations guides

The most comprehensive online source for medical tourism information, myMEDholiday.com, has launched a series of digital guides that provide detailed information about 16 popular medical tourism destinations. The destinations in the range so far include: Thailand, Brazil, Costa Rica, Mexico, Malaysia, Panama, Greece, India, Hungary, and many more.

4 Dec 2014

Thomson Reuters, Linguamatics launch Cortellis Informatics Clinical Text Analytics for I2E

The Intellectual Property & Science business of Thomson Reuters, the world leader in intelligent information for businesses and professionals, today announced a collaboration with Linguamatics to advance pharmaceutical clinical trial research and development (R&D) with the launch of Cortellis Informatics Clinical Text Analytics for I2E.

4 Dec 2014

BeyondSpring Pharmaceuticals plans to initiate Plinabulin Phase 3 pivotal trial in NSCLC patients

BeyondSpring Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today announced that it plans to initiate a Phase 3 pivotal trial of lead product candidate, Plinabulin, in patients with non-small cell lung cancer (NSCLC) in the first quarter of 2015.

4 Dec 2014

Oncologists examine efficacy of rose bengal against cancer

Rose Bengal has been around for decades starting as a way to dye wool. Originally used in medicine as a stain for ophthalmologists, it has a solid safety record going back to the 1930s. Recently, oncologists have examined its efficacy against cancer, specifically melanoma.

4 Dec 2014

Elsevier announces recipients for Innovative Libraries in Developing Countries and New Scholars Programs

The Elsevier Foundation today announced its 2015 grant recipients for the Innovative Libraries in Developing Countries and New Scholars Programs. In total $600.000 has been committed for 2015 that will support various multiyear projects in over 20 countries in the developing world.

4 Dec 2014

New collaborative project aims to generate 3% productivity boost at Australian pharmaceutical sites

META, a collaborative network of high potential manufacturing businesses and researchers, has today announced a collaborative project between Hospira, GlaxoSmithKline and CSL to generate a targeted 3% productivity boost with an estimated return on investment of up to $2.4M dollars at Australian pharmaceutical sites.

4 Dec 2014

Peterson Center on Healthcare announces three major initiatives to improve U.S. healthcare

Today, the Peterson Center on Healthcare, a new organization established by the Peter G. Peterson Foundation, announced three major initiatives to advance the Center's mission to transform U.S. healthcare into a high-performance system that delivers high-quality care at a lower cost.

4 Dec 2014

$TxCell enrolls first patient in Ovasave phase IIb trial for treatment of refractory Crohn’s disease$

TxCell enrolls first patient in Ovasave phase IIb trial for treatment of refractory Crohn’s disease

TxCell SA, a biotechnology company developing novel and innovative, cost-effective personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that it has enrolled the first patient in its phase IIb clinical trial of its lead product Ovasave in refractory Crohn’s disease.

4 Dec 2014

World-renowned experts to discuss challenges of antibiotic resistance at Murdoch University symposium

World-renowned experts in the fields of antibiotic resistance will come together at a symposium at Murdoch University to talk about an issue which has the potential to become one of the world’s biggest public health challenges.

4 Dec 2014

Endocrinologist examines benefits and harms of testosterone therapy

An article in the latest edition of Australian Prescriber looks at the prescribing of testosterone, often used for ‘male menopause’ symptoms such as reduced energy, poor concentration and increased body fat. Over the past decade there has been a steep rise in the amount of testosterone dispensed in Australia and globally.

4 Dec 2014

New Griffith research aims to support women in abusive relationships

In Australia, one woman a week is murdered as a result of a domestic violence attack. 30 per cent of domestic violence incidents occur during pregnancy.

4 Dec 2014

Medical News

BME announces launch of Speed Arc Nitinol Fixation System

CorMedix seeks QIDP designation from FDA for Neutrolin Catheter Lock Solution

Dr. Peter G. Goldschmidt announces recipients of Awards for Excellence in Human Research Protection

Mylan gets tentative approval from FDA for two pediatric dosages of abacavir/lamivudine tablets

Welch Allyn, LKC Technologies sign distribution agreement for RETeval DR screening device

MRIGlobal awarded $3 million contract to provide HPV vaccine

New drug offers hope for victims of spinal cord injury

Massage therapy: A natural way to strengthen the immune system this flu season

Pharmacyclics wins 2014 Society for Medicines Research Award for Drug Discovery

myMEDholiday.com launches digital medical tourism destinations guides

Thomson Reuters, Linguamatics launch Cortellis Informatics Clinical Text Analytics for I2E

BeyondSpring Pharmaceuticals plans to initiate Plinabulin Phase 3 pivotal trial in NSCLC patients

Oncologists examine efficacy of rose bengal against cancer

Elsevier announces recipients for Innovative Libraries in Developing Countries and New Scholars Programs

New collaborative project aims to generate 3% productivity boost at Australian pharmaceutical sites

Peterson Center on Healthcare announces three major initiatives to improve U.S. healthcare

TxCell enrolls first patient in Ovasave phase IIb trial for treatment of refractory Crohn’s disease

World-renowned experts to discuss challenges of antibiotic resistance at Murdoch University symposium

Endocrinologist examines benefits and harms of testosterone therapy

New Griffith research aims to support women in abusive relationships

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News